Leyton Connect is a serie of events during which the customer is at the heart of our strategy.
The objective? To exchange ideas during a Breakfast & Conference on a current issue, and to help our respective companies evolve by learning from the different points of view of our guests. Our aim is to equip these business players with concrete strategies for exponential growth. More broadly, through this event, we aim to create a dynamic and collaborative community between entrepreneurs, startups and SMEs (Small and Medium-sized Enterprises).
For the first edition, we were delighted to welcome Laurent Tillement, Director, Partnerships – AI & Health, at Mila, accompanied by Laurent Lecanu, Business Development Manager – Pharma Division for Leyton. They spoke at a Breakfast & Conference on the impact of AI on life sciences and Mila’s role in supporting its adoption in Quebec.
Find out more about our speakers:
- Laurent Tillement: Laurent is the Director of AI & Health Partnerships at Mila – Quebec Artificial Intelligence Institute.He holds a PharmD (Paris) and a PhD in Biochemistry and Molecular Biology (Georgetown University, Washington D.C.), and brings extensive experience in academic and industrial pharmaceutical research across France, the United States, and Canada.His expertise spans the full drug development cycle—from exploratory research to clinical trials—with a particular focus on integrating innovation into pharmaceutical processes.At Mila, he leads the institute’s engagement with the life sciences ecosystem, building strategic partnerships and promoting research collaborations to accelerate the adoption of AI in healthcare.
- Laurent Lecanu: Laurent is a seasoned expert in innovation funding, with a specialization in the life sciences and biotechnology sectors.Currently Business Development Manager at Leyton Canada, he helps companies optimize their R&D projects, particularly through programs such as the Scientific Research and Experimental Development (SR&ED) tax credit.With over 15 years of experience in both public and private financing, Laurent is recognized as a trusted strategic advisor for innovative organizations.He recently represented Leyton at the Life Sciences Partnering Canada event in Ottawa, where he presented the various funding opportunities available to stakeholders in the pharmaceutical and biotech industries.
If you’d like to find out more about our services, contact our experts.
